SCHEMBL5651

SCHEMBL5651

CCC[C@]1(O)CC[C@]2(CCN(c3ccc(C(C)(C)C)cc3)C2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 1/20 0.38
CYP3A4 P08684 7/20 0.34
CYP2C19 P33261 4/20 0.34
ALDH1A1 P00352 4/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HIF1A Q16665 3/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
USP2 O75604 3/20 0.34
CYP1A2 P05177 3/20 0.34
CYP2C9 P11712 3/20 0.34
HSD17B10 Q99714 3/20 0.34
HPGD P15428 2/20 0.34
ALOX15 P16050 2/20 0.34
ITGB3 P05106 4/20 0.34
ITGA2B P08514 4/20 0.34
HSD11B1 P28845 1/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 2/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5989 0.84 CYP3A4 (0.40) CYP3A4CYP2C19ALDH1A1SMN1; SMN2HIF1A
SCHEMBL5924 0.81 ITGB3 (0.38) LIPECYP3A4CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL5614 0.81 LIPE (0.60) LIPE
SCHEMBL5391 0.81 CYP3A4 (0.35) CYP3A4CYP2C19ALDH1A1SMN1; SMN2HIF1A
SCHEMBL5406 0.80 KCNJ1 (0.39) LIPECYP3A4CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL4615 0.79 HSD11B1 (0.42) CYP3A4CYP2C19ALDH1A1SMN1; SMN2HIF1A
SCHEMBL5548 0.79 CYP3A4 (0.36) CYP3A4CYP2C19ALDH1A1SMN1; SMN2HIF1A
SCHEMBL5639 0.78 S1PR1 (0.41) LIPECYP3A4CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL25675738 0.78 HSD11B1 (0.40) CYP3A4CYP2C19ALDH1A1SMN1; SMN2HIF1A
SCHEMBL4962 0.77 RYR2 (0.41) LIPECYP3A4CYP2C19ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed